Encompass Health Corporation reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 1,246.8 million compared to USD 1,137.3 million a year ago. Net income was USD 87.6 million compared to USD 89.4 million a year ago. Basic earnings per share from continuing operations was USD 0.96 compared to USD 0.91 a year ago. Diluted earnings per share from continuing operations was USD 0.94 compared to USD 0.9 a year ago. Basic earnings per share was USD 0.87 compared to USD 0.89 a year ago. Diluted earnings per share was USD 0.86 compared to USD 0.89 a year ago.
For the full year, sales was USD 4,801.2 million compared to USD 4,348.6 million a year ago. Net income was USD 352 million compared to USD 271 million a year ago. Basic earnings per share from continuing operations was USD 3.63 compared to USD 2.58 a year ago. Diluted earnings per share from continuing operations was USD 3.59 compared to USD 2.56 a year ago. Basic earnings per share was USD 3.51 compared to USD 2.72 a year ago. Diluted earnings per share was USD 3.47 compared to USD 2.7 a year ago.